Nurix Therapeutics Inc

Mid-Cap Stocks Biotech Stocks Healthcare Stocks

$25.16

-0.06 (-0.24%)

As of Aug 8, 1:38 AM ET ·

Analyst Consensus

Strong Buy

Analysts

High

Coverage

Buy 20 91%

Hold 2 9%

Sell 0 0%

Price Target

Analyst Price Target +187.3% upside

Low Target $45.76

Average Target $72.29

High Target $82.91

Current Price $25.16

Current
$25.16

Target
$72.29

$45.76 $72.29 avg $82.91

Scenario Analysis

Bear Case

$45.76

81.9%

Low target

Base Case

$72.29

+187.3%

Avg target

Bull Case

$82.91

+229.5%

High target

Risk/Reward

2.8x

Favorable

Price in Context

52-Week High

$25.49

-1.3% from high

52-Week Low

$8.20

+207.0% from low

Target vs 52W High

$72.29

+183.6% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	39	79%	$257.58	+4.7%
AMGN Amgen Inc	Hold	43	49%	$190.87	-53.6%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+172.3%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-11.6%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-90.2%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-55.6%
RVMD Revolution Medicines Inc	Strong Buy	29	93%	$114.11	-44.4%
BIIB Biogen Inc	Buy	44	64%	$91.45	-56.0%